(Total Views: 80)
Posted On: 10/08/2019 10:20:43 AM
Post# of 85480

$VTGN News Article - VistaGen Therapeutics Announces Last Patient Completes Dosing in the ELEVATE Phase 2 Clinical Study of AV-101 for Major Depressive Disorder https://marketwirenews.com/news-releases/vist...11054.html


My Twitter: WhyteStocks